Evidence map›Paper›PMID 41046471›Full record

ArticleMedical physics2025

Three-dimensional proton FLASH dose rate measurement at high spatiotemporal resolution using a novel multi-layer strip ionization chamber (MLSIC) device.

Shuang Zhou, Arash Darafsheh, Zhiyan Xiao, Anthony Mascia, Yongbing Zhang, Jun Zhou, Liyong Lin, David Zhang, Liuxing Shen, Hao Jiang and 4 more

Abstract read
In one paragraph

Article in Medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Shuang ZhouDepartment of Radiation Oncology, WashU Medicine, St. Louis, Missouri, USA.
Arash DarafshehDepartment of Radiation Oncology, WashU Medicine, St. Louis, Missouri, USA.ORCID https://orcid.org/0000-0003-4148-0891
Zhiyan XiaoDepartment of Radiation Oncology, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Anthony MasciaDepartment of Radiation Oncology, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Yongbing ZhangDepartment of Radiation Oncology, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Jun ZhouDepartment of Radiation Oncology, Emory University, Emory Proton Therapy Center, Atlanta, Georgia, USA.
Liyong LinDepartment of Radiation Oncology, Emory University, Emory Proton Therapy Center, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0002-0820-8063
David ZhangTetraImaging LLC, St. Louis, Missouri, USA.
Liuxing ShenTetraImaging LLC, St. Louis, Missouri, USA.
Hao JiangTetraImaging LLC, St. Louis, Missouri, USA.
Qinghao ChenDepartment of Radiation Oncology, WashU Medicine, St. Louis, Missouri, USA.
Tianyu ZhaoDepartment of Radiation Oncology, WashU Medicine, St. Louis, Missouri, USA.
Stephanie PerkinsDepartment of Radiation Oncology, WashU Medicine, St. Louis, Missouri, USA.
Tiezhi ZhangDepartment of Radiation Oncology, WashU Medicine, St. Louis, Missouri, USA.

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
SBIR TOPIC 434 PHASE II: DEVELOPMENT OF MULTILAYER STRIP ION CHAMBER DEVICE FOR THE MEASUREMENT OF FLASH-RT BEAMSPERIOD OF PERFORMANCE: 9/16/24-9/15/2675N91024C00084 · NCI · TETRAIMAGING, LLC · PI JIANG, HAO · 2024 to 2024
$2.0M
Foundation for Barnes-Jewish HospitalNCATS NIH HHS UL1 TR002345NCI NIH HHS 75N91024C00084
6 · The paper itself

Abstract

backgroundCurrently, proton therapy is the main radiation treatment modality that can treat deeply seated targets at ultra-high dose rates. The safe translation of FLASH RT into clinic requires dedicated dosimeters capable of measurements at sufficiently high spatiotemporal resolution. PURPOSE: The objective of this work is to demonstrate the feasibility of three-dimensional (3D) measurements of dose rate and dose for FLASH pencil beam scanning (PBS) proton therapy.

methodsA multi-layer strip ionization chamber (MLSIC) device, along with a reconstruction algorithm, was designed and developed to reconstruct dose and dose rate distribution over a 3D volume. Our MLSIC is composed of 66 layers of strip ionization chamber arrays with total water-equivalent thickness (WET) of 19.2 cm along the beam direction. The first two layers, composed of 128 channels with orthogonal direction with respect to each other, provide the (x,y) coordinate. The other 64 layers contain 32 channels with 8 mm lateral spacing. Data readout at a high-speed of 6250 fps allows spot-by-spot measurement. To prove the concept, PBS proton therapy plans were delivered at conventional and FLASH dose rates. Dose and dose rate information were reconstructed in 3D using an in-house reconstruction algorithm.

resultsIon recombination remained under 1% in the majority of cases. 3D dose reconstruction showed agreement with the treatment planning software; the 3D gamma analysis of the reconstructed dose showed 96.2% (5 mm/5%) and 86.8% (3 mm/3%) passing rates with 10% threshold for the conventional dose rate plan, 99.1% (5 mm/5%) and 92.6% (3 mm/3%) passing rates for the FLASH dose rate plan. 3D dose rate distributions were successfully generated using different definitions.

conclusionsOur MLSIC device allows obtaining 3D dose and dose rate distribution of PBS proton beams at FLASH dose rates with high spatiotemporal resolution.

Indexed as

Proton TherapyRadiation DosageRadiometryAlgorithmsRadiotherapy DosageRadiotherapy Planning, Computer-Assisted3D dosimetryFLASHionization chamberproton therapyultra‐high dose rate

Identifiers

PMID41046471
PMCPMC12679469

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.